<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="62119">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01967836</url>
  </required_header>
  <id_info>
    <org_study_id>13-059</org_study_id>
    <nct_id>NCT01967836</nct_id>
  </id_info>
  <brief_title>Glad Press 'n Seal® as a Temporary Moisture Barrier to Central Lines in Ambulatory Oncology Patients</brief_title>
  <official_title>Glad Press 'n Seal® as a Temporary Moisture Barrier to Central Lines in Ambulatory Oncology Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maureen T Greene</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wheaton Franciscan Healthcare</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to see if Glad Press 'n Seal works as a moisture barrier for
      central line that is left in place during ambulatory oncology clinical care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Enrolled subjects will be instructed on the application of the Glad Press 'n Seal product to
      their IV dressing for use during a shower activity. Practice with application and removal of
      the product will be supervised by the PI or RA. Questions will be answers and a box of the
      investigational product will be given to the subject for home use.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Subject satisfaction with Glad press 'n Seal as a central line moisture barrier</measure>
    <time_frame>Self-report questionnaires will be completed after an average of 3 showers</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient satisfaction with the use of the product for IV site protection dueing shower</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinic nurse observation</measure>
    <time_frame>1 week on average to next clinic visit</time_frame>
    <safety_issue>No</safety_issue>
    <description>The secondary outcomes of the study are clinic nurse observed problems (lack of adherence of the product to the skin during use, ease of use of the product, presence/absence of local skin irritation, intactness/ dislodgement of the IV line/needle) with the IV site upon subject return to the clinic and verification by the subject (through the return of the subject questionnaires) that the Glad Press 'n Seal product was used during home showering.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Cancer-related Problem/Condition</condition>
  <arm_group>
    <arm_group_label>Glad Press 'n Seal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will use Glad Press 'n Seal product as a moisture barrier to an IV line</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Glad Press 'n Seal</intervention_name>
    <description>Application of Glad Press n' Seal product as an IV site dressing protection during subject showering</description>
    <arm_group_label>Glad Press 'n Seal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects requiring mediport or peripherally inserted central venous catheter line
             access for 3-5 days

          -  Able to read and write English

        Exclusion Criteria:

          -  Subjects with eczema/psoriasis at the line insertion area

          -  Subjects with active line/site irritation/infection

          -  Subjects on chemotherapy protocols including anti-epidermal growth factor receptor
             drugs (cetuximab, panitumumab) or ipilimumab as there is a high incidence of skin
             rash as a side effect of these medications

          -  Patients who do not intend to shower as a means of home hygiene
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maureen T Greene, PhD, RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wheaton Franciscan Healthcare</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maureen T Greene, PhD, RN</last_name>
    <phone>414-447-2716</phone>
    <email>maureen.greene@wfhc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mary Ann Biederwolf, RN, OCN</last_name>
    <phone>414-647-5503</phone>
    <email>maryann.biederwolf@wfhc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>WFH-St. Francis</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Ann Biederwolf, BSN</last_name>
      <phone>414-647-5503</phone>
      <email>maryann.biederwolf@wfhc.org</email>
    </contact>
    <contact_backup>
      <last_name>Maureen T Greene, PhD</last_name>
      <phone>414-447-2716</phone>
      <email>maureen.greene@wfhc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Rieman Cancer Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cathy Schott, BSN</last_name>
      <phone>414-427-2396</phone>
      <email>Catherine.Schott@wfhc.org</email>
    </contact>
    <contact_backup>
      <last_name>Barbara Schmidt, BSN</last_name>
      <phone>414-</phone>
      <email>barbara.Schmidt@wfhc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Wheaton Franciscan - Wauwatosa Campus</name>
      <address>
        <city>Wauwatosa</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pamela Phillips, BSN</last_name>
      <phone>414-259-7486</phone>
      <email>pamela.phillips@wfhc.org</email>
    </contact>
    <contact_backup>
      <last_name>Beth Schmitt, MS</last_name>
      <phone>414-256-1943</phone>
      <email>beth.schmitt@wfhc.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 26, 2014</lastchanged_date>
  <firstreceived_date>October 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Wheaton Franciscan Healthcare</investigator_affiliation>
    <investigator_full_name>Maureen T Greene</investigator_full_name>
    <investigator_title>Maureen T. Greene, PhD, RN</investigator_title>
  </responsible_party>
  <keyword>Invasive Line</keyword>
  <keyword>IV Dressing protection</keyword>
  <keyword>Hygiene</keyword>
  <keyword>Oncology</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
